Suchergebnisse - "Daneshmand, Siamak"

PubPharm (709)

1

Surveillance of non-muscle-invasive bladder cancer with blue-light cystoscopy : a meta-analysis

enthalten in: BJU international | 2024

von Sari Motlagh, R. | Ghoreifi, A. | Yanagisawa, T. | +8

2

Author Correction : Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial

enthalten in: Nature medicine | 2024

von Galsky, M. | Daneshmand, S. | Izadmehr, S. | +37

ErratumFor: Nat Med. 2023 Nov;29(11):2825-2834. - PMID 37783966

3

Prophylactic Use of Biologic Mesh in Ileal Conduit (PUBMIC) : A Randomized Clinical Trial

enthalten in: The Journal of urology | 2024

von Djaladat, H. | Ghoreifi, A. | Tejura, T. | +12

4

Interruptions in bladder cancer care during the COVID-19 public health emergency

enthalten in: Urologic oncology | 2024

von Gore, J. | Follmer, K. | Reynolds, J. | +33

5

Blood-based liquid biopsy : A promising noninvasive test in diagnosis, surveillance, and prognosis of patients with upper tract urothelial carcinoma

enthalten in: Urologic oncology | 2024

von Ghoreifi, A. | Shishido, S. | Sayeed, S. | +10

6

Infigratinib Versus Placebo for Patients with High-risk Resected Urothelial Cancer Bearing an FGFR3 Genomic Alteration : Results from the PROOF302 Phase 3 Trial

enthalten in: European urology | 2024

von Pal, S. | Grivas, P. | Gupta, S. | +19

7

Racial Differences in the Detection Rate of Bladder Cancer Using Blue Light Cystoscopy : Insights from a Multicenter Registry

enthalten in: Cancers | 2024

von Ladi-Seyedian, S. | Ghoreifi, A. | Konety, B. | +14

8

The effect of enhanced recovery after surgery on oncologic outcome following radical cystectomy for urothelial bladder carcinoma

enthalten in: Surgical oncology | 2024

von Ma, R. | Sheybaee Moghaddam, F. | Ghoreifi, A. | +9

9

Comparative cost-effectiveness of contemporary treatment strategies for stage IIA seminoma

enthalten in: Journal of the National Cancer Institute | 2024

von Joyce, D. | Sharma, V. | Wymer, K. | +8

10

Updated Overall Survival by Circulating Tumor DNA Status from the Phase 3 IMvigor010 Trial : Adjuvant Atezolizumab Versus Observation in Muscle-invasive Urothelial Carcinoma

enthalten in: European urology | 2024

von Powles, T. | Assaf, Z. | Degaonkar, V. | +16

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[71]